Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide Compared to Lenalidomide Alone in Multiple Myeloma Patients

Trial Overview

Am I Eligible?

Participating US Centers

Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine

This center is currently accepting patients.

Baltimore, MD

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 2

Trial Enrollment

56 sparks required

Trial Sponsors
  • Johns Hopkins Medicine (Sidney Kimmel Comprehensive Cancer Center
Trial Collaborators
  • Celgene Corporation
  • Aduro Biotech, Inc.
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;